Seeking Alpha

Onco-Innovations Engages the University of Alberta and Cross Cancer Institute to Expand PNKP Inhibitor Research into Hard-to-Treat Cancers

VANCOUVER, BC / ACCESS Newswire / June 13, 2025 / Onco-Innovations Limited (ONCO:CA)(Frankfurt:W1H,WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce that it has entered into an agreement ...
Morningstar

Onco-Innovations Engages the University of Alberta and Cross Cancer Institute to Expand PNKP Inhibitor Research into Hard-to-Treat Cancers

Important factors that could cause actual results to differ materially from the Company's expectations include the failure to pursue an engagement with the University of Albert or Cross-Cancer ...